Real Housewives of Beverly Hills alum Teddi Mellencamp celebrated the end of her radiation treatments as she continues to ...

Treatments such as the Mohs procedure and fluorouracil can be effective in the fight against the most common type of cancer ...

Young people are chasing a golden glow through indoor tanning in spite of the health risks. Katie Rosseinsky explores how sunbeds got a Gen Z-friendly rebrand ...

In 2021, the Conclave star shared he underwent chemotherapy and radiation after ... was treated for his third basal cell carcinoma back in 2014, and after his third treatment, Jackman's rep ...

Century Therapeutics has joined the onslaught of cell therapy biotechs taking hits, discontinuing a phase 1 cancer study to turn its focus toward autoimmune diseases. The move isn’t shocking ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Researchers analyzed data from more than 5,800 patients in seven clinical trials to compare standard therapy with two forms of MHFRT. The study found that isodose MHFRT had a five-year progression ...

So this way, while they are waiting to have their surgery and they are meeting with a plastic surgeon and they are getting all their pre op testing, they get a week of radiation under their belt, and ...

A study published in The Lancet Haematology has reported a 73% response rate for CAR T-cell therapy among patients with certain blood cancers. The clinical trials were conducted by researchers ...

Before those cells can be infused as treatment, a patient must undergo a conditioning regimen that kill off immune cells to make room for the cells in the cell therapy. This step also prevents the ...

Susan Galbraith, executive vice-president of oncology R&D at AstraZeneca, said the deal “has the potential to transform cell therapy and will enable us to scale these innovative treatments so ...

AstraZeneca is fronting $425 million, with an additional $575 million on the line to acquire Belgium-based EsoBiotec and its cell therapy-focused pipeline and platform, according to a news release on ...